Antiphospholipid Syndrome: Clinical Trials

6 trials for Antiphospholipid Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 2 unknown, 1 completed, 1 not yet recruiting. 6 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 36Terminated 2, Unknown 2, Completed 1, Not yet recruiting 1
Phase 21Unknown 1

Follow Antiphospholipid Syndrome: new trials by email Literature Review of Antiphospholipid Syndrome trials Research Report on Antiphospholipid Syndrome

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Anticoagulant Cessation After Antiphospholipid Autoantibodies Loss in Thrombotic Antiphospholipid Syndrome
Vitamin K Antagonist - Drug, Anticoagulant Therapy Discontinuation - Antiphospholipid Syndrome, Thrombotic Antiphospholipid Syndrome
Phase 3Not yet recruitingAssistance Publique - Hôpitaux de Paris2342026-12-012026-10-15
The BeLimumab Antiphospholipid Syndrome Trial (BLAST)
Belimumab - Antiphospholipid Syndrome
Phase 2 / Phase 3UnknownUniversity of Turin, Italy152022-06-012023-01-13
Hydroxychloroquine Versus Placebo: Impact on Thrombotic Relapse in Primary Antiphospholipid Syndrome
Hydroxychloroquine, Placebo - Primary Antiphospholipid Syndrome
Phase 3UnknownUniversity Hospital, Angers3002018-08-152018-05-30
Rivaroxaban in Thrombotic Antiphospholipid Syndrome
Experimental: Rivaroxaban - Antiphospholipid Syndrome
Phase 3TerminatedUniversity of Padova1212014-12-012018-01-30
Rivaroxaban for Patients With Antiphospholipid Syndrome
Rivaroxaban, acenocumarol - Antiphospholipid Syndrome
Phase 3CompletedHospital Universitari Vall d'Hebron Research Institute1902013-03-132018-05-11
Hydroxychloroquine for the First Thrombosis Prevention in Antiphospholipid Antibody Positive Patients
Hydroxychloroquine - Antiphospholipid Syndrome
Phase 3TerminatedHospital for Special Surgery, New York112013-02-012021-09-14

Narrower conditions

Thrombosis (3)  ·  Syndrome (1)

Broader conditions

Autoimmune Diseases (6)  ·  Immune System Diseases (6)  ·  Cardiovascular Diseases (3)  ·  Embolism and Thrombosis (3)  ·  Vascular Diseases (3)  ·  Disease (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Acenocoumarol (2)  ·  Hydroxychloroquine (2)  ·  Rivaroxaban (2)  ·  belimumab (1)  ·  fluindione (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Hospital Universitari Vall d'Hebron Research Institute (1)  ·  Hospital for Special Surgery, New York (1)  ·  University Hospital, Angers (1)  ·  University of Padova (1)  ·  University of Turin, Italy (1)

Countries

France (2)  ·  Italy (2)  ·  Spain (1)  ·  United States (1)

Top investigators

Cristina Belizna, MD, PhD (1)  ·  Doruk Erkan, MD (1)  ·  Josefina Cortes, MD,pHD (1)

Results publications

PMID 30002145, PMID 37422199, PMID 40934736

NIH funding

2017 (1)